Project Grant R16GM146704

Award Date 9/20/22
Completion Date 7/31/26
Dollars Obligated $865K
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
Arkadelphia, AR 71998, USA
Similar Awards
The National Institute of General Medical Sciences (NIGMS) awarded a $400,000 Project Grant under the Biomedical Research and Research Training (CFDA 93.859) program to Baylor College of Medicine to develop and optimize bioengineered polymers that can modulate inflammatory responses and enhance tissue repair and regeneration in wound healing. The 5-year project aims to systematically investigate how the chemical and mechanical properties of biopolymers, such as surface charges, elasticity, and...
This $1,017,602 National Science Foundation project grant supports research at North Carolina State University to develop microphysiological models for evaluating the role of age-dependent fibrinogen sialylation in wound healing. The three-year award under the NSF Engineering program (CFDA 47.041) will fund the creation of innovative tissue engineering techniques and microfluidic systems to study interactions between platelets and fibroblasts during wound healing. Researchers aim to better...
This National Science Foundation (NSF) Engineering Research Initiation (ERI) Project Grant, awarded by the NSF Division of Chemical, Bioengineering, Environmental, and Transport Systems, aims to develop a new type of bioadhesive using hydrophilic polydopamine (HPDA) to improve healing of inner meniscus tears. The project will synthesize and characterize HPDA, then incorporate it into hydrogel-based bioadhesives to be tested in vitro. The specific objectives are to understand the adhesion...
The National Heart, Lung, and Blood Institute (NHLBI), through the Cardiovascular Diseases Research (CFDA 93.837) federal grant program, awarded a $1,249,317 Project Grant to Sanaheal Inc. for the development and validation of a "Hemostatic Bioadhesive Paste for Coagulation-Independent Rapid Control of Bleeding." The objective is to optimize and validate this hemostatic paste to meet FDA regulatory requirements in preparation for a future pivotal clinical trial and commercialization....
This National Science Foundation Project Grant of $100,000 supports research into polyelectrolyte multilayered surfaces for use in human mesenchymal stem/stromal cell manufacturing. The goal is to develop a scalable and controllable polymeric coating composed of natural polymers to improve the cell expansion process used in producing therapeutic human mesenchymal stromal cells. The coating is constructed via layer-by-layer assembly of collagen and heparin and has been shown to increase cell...
This $863,697 Project Grant from the National Institutes of Health's National Institute of General Medical Sciences will support Provenance Group Inc.'s efforts to efficiently synthesize full-length human Type I collagen with appropriate post-translational modifications at high yields. The company will demonstrate that the recombinant collagen resembles its native counterpart and generate highly productive strains expressing full-length human Type I collagen showing appropriate prolyl...
This Project Grant from the National Science Foundation Division of Materials Research provides $418,382 to Rensselaer Polytechnic Institute for research under the Mathematical and Physical Sciences program (CFDA 47.049). The award will fund development of novel implantable biomaterials composed of polymerized prodrugs of 17?-estradiol formulated as oriented electrospun microfibers embedded in an injectable hydrogel matrix. These materials are designed to slowly degrade via hydrolysis...
This $240,412 Project Grant award from the National Science Foundation (NSF) Engineering Program (CFDA 47.041) supports collaborative research at East Carolina University (ECU) to investigate how tension affects the digestion of blood clots. The research aims to test hypotheses about how inherent and applied tension on fibrin fibers impact the fibrinolysis process, which is essential for the proper dissolution of blood clots to prevent risks like strokes and heart attacks. The...
The National Science Foundation (NSF) has awarded a 5-year, $182,664 CAREER grant (CFDA 47.041 - Engineering program) to the Marshall University Research Corporation (MURC) to explore the use of electrospinning and electrospraying techniques for differentiating human adipose-derived stem cells into chondrocytes. The overarching goal is to develop an innovative and personalized approach to generate chondrocytes, or cartilage cells, that can be used for regenerative medicine applications focused...
The National Science Foundation awarded a $750,000 Project Grant to Rutgers, The State University under the Engineering program (CFDA 47.041) from September 1, 2022 to August 31, 2025. The grant funds research to develop an injectable nanoparticle therapy to restore strength and length to damaged tendons and ligaments. Specifically, the university will investigate combining a thermosensitive polymer and crosslinking agent to stabilize joints by quickly strengthening and returning tissues like...

DEVELOPMENT OF DEGRADABLE FIBERS WITH HEMOSTATIC PROPERTIES - PROJECT SUMMARY RECENT EVOLUTIONS IN THE FIELD OF HEMOSTATIC MATERIALS HAVE FOCUSED ON DEVELOPING PRODUCTS WITH HIGH HEMOSTATIC EFFICIENCY. AN IDEAL HEMOSTATIC MATERIAL SHOULD QUICKLY CONTROL HEMORRHAGING, EXHIBIT BIOCOMPATIBILITY AND DEGRADABILITY, PROMOTE WOUND HEALING AND BE LIGHTWEIGHT AND INEXPENSIVE. ELECTROSPINNING DEGRADABLE MACROMOLECULES LIKE COLLAGEN, CHITOSAN, POLYCAPROLACTONE YIELDS NANOFIBER WHICH HAVE SHOWN PROMISE IN WOUND HEALING AND BLEEDING CESSATION APPLICATIONS. MODERN BLEEDING CESSATION TREATMENTS SHOULD HAVE DEGRADABLE AND REGENERATIVE CAPABILITIES BUT LITTLE RESEARCH HAS BEEN PUBLISHED ON THE UTILIZATION OF SYNTHETIC ANALOGS TO COSTLY BIOMOLECULES. THE LONG-TERM GOAL OF THIS PROJECT IS TO GENERATE A BETTER UNDERSTANDING OF POLYMER-BASED HEMOSTATIC WOUND HEALING MATERIALS AND CELLULAR RESPONSES TOWARDS THESE MATERIALS FOR IMPLEMENTATION IN REGENERATIVE TREATMENTS. AS A STEP TOWARDS THIS GOAL, A DEGRADABLE COLLAGEN STRAND ANALOG MUST BE SYNTHESIZED, ELECTROSPUN, AND COMPARED TO OTHER SCAFFOLDS FOR IN VITRO AND IN VIVO EVALUATION. IT IS HYPOTHESIZED THAT A BIOMIMETIC SYNTHETIC POLYMER CAN BE ELECTROSPUN INTO AN AFFORDABLE, BIOCOMPATIBLE, DEGRADABLE, HEMOSTATIC WOUND DRESSING MATERIAL THAT WILL NOT ONLY CATALYZE COAGULATION BUT ALSO WILL NOT REQUIRE SURGICAL REMOVAL. THIS PROPOSAL IS SIGNIFICANT BECAUSE IT REPRESENTS THE FIRST ATTEMPT TO INCORPORATE A POLYESTER-BASED COLLAGEN MIMIC INTO ELECTROSPUN SCAFFOLDS WITH THE ABILITY TO CONTROL SCAFFOLD COMPOSITION TO COMBINE DESIRED PROPERTIES AND FUNCTIONALITIES IN AN IDEAL MATERIAL FOR WOUND HEALING AND HEMOSTATIC APPLICATIONS. THIS APPROACH IS INNOVATIVE BECAUSE IT WILL DETERMINE THE FEASIBILITY OF UTILIZING A SYNTHETIC COLLAGEN MIMIC IN APPLICATIONS SUCH AS ELECTROSPUN WOUND HEALING AND BLEEDING CESSATION MATERIALS. IT IS ANTICIPATED THAT THE COLLAGEN-LIKE FUNCTIONAL GROUPS ON THE NOVEL POLYESTER COUPLED WITH THE PRESENCE OF CHITOSAN IN THE FIBERS WILL LEAD TO BLEEDING CESSATION IN WOUND MODELS WITH SUITABLE DEGRADATION RATES. FURTHERMORE, UNDERGRADUATE STUDENTS WILL CONDUCT THE MAJORITY OF THE RESEARCH IN THIS PROPOSAL. THIS WILL BE A SIGNIFICANT RESEARCH EXPERIENCE FOR THESE STUDENTS AND WILL PROVIDE THEM WITH VALUABLE LABORATORY AND RESEARCH SKILLS THAT WILL BE ESSENTIAL IN THEIR CAREERS.

Posted 9/20/22, 12:00 AM